Related Experiment Video
Updated: Apr 3, 2026

04:42
Treating Low Back Pain in Failed Back Surgery Patients with Multicolumn-lead Spinal Cord Stimulation
Published on: June 26, 2018
15.3K
The Effectiveness and Cost-Effectiveness of Spinal Cord Stimulation for Refractory Angina (RASCAL Study): A Pilot
Sam Eldabe1, Simon Thomson2, Rui Duarte3
1Department of Pain and Anesthesia, The James Cook University Hospital, Middlesbrough, UK.
Neuromodulation : Journal of the International Neuromodulation Society
|September 22, 2015
Summary
Recruiting patients for spinal cord stimulation (SCS) trials for refractory angina (RA) proved challenging, but retention and acceptability were high. This pilot study offers lessons for future definitive trials comparing SCS with usual care.
Area of Science:
- Cardiovascular Medicine
- Neurosurgery
- Clinical Trial Design
Background:
- Refractory angina (RA) patients face poor quality of life and high hospitalization rates.
- Spinal cord stimulation (SCS) shows promise for angina, but trials comparing it to usual care (UC) are lacking.
- Pilot studies are crucial for addressing uncertainties in definitive trials for SCS in RA.
Purpose of the Study:
- To assess the feasibility of a definitive multicenter trial for SCS in RA patients.
- To evaluate recruitment, retention, and standardization of UC.
- To determine the acceptability of SCS and proposed outcome measures.
Main Methods:
- Randomized pilot study comparing SCS plus UC versus UC alone in RA patients.
- Assessed recruitment, patient retention, and feasibility of standardizing UC.
- Evaluated SCS treatment acceptability and trial outcome measures at baseline and 6 months.
Main Results:
- Recruitment fell short of the target, with 29 patients randomized over 42 months.
- High patient retention and outcome completion rates were observed.
- A trend towards greater improvement in outcomes favored the SCS group.
Conclusions:
- Participant retention, outcome completion, and SCS acceptability were high.
- Patient recruitment for SCS trials in RA presents challenges.
- Lessons learned will inform the design of future definitive pragmatic randomized trials.

